Login / Signup

Growth Hormone: A Potential Treatment of Patients with Refractory Thin Endometrium: A Clinical Trial Study.

Soghra Hosseini AghdamAlyeh GhasemzadehLaya FarzadiKobra HamdiMarayam Baradaran-BinazirMohammad NouriAmir FattahiRalf Dttrich
Published in: International journal of fertility & sterility (2022)
The intrauterine administration of GH could be an appropriate therapeutic strategy for patients with refractory thin endometrium. This treatment could significantly increase the EMT as well as implantation and pregnancy rates in these patients (registration number: IRCT20210220050429N1).
Keyphrases
  • growth hormone
  • clinical trial
  • newly diagnosed
  • ejection fraction
  • combination therapy
  • prognostic factors
  • signaling pathway
  • study protocol
  • open label
  • double blind
  • replacement therapy
  • smoking cessation